Open AccessResults of a Phase I Trial of Induction Cisplatin, Docetaxel, 5-FU and Erlotinib Followed by Cisplatin, Bevacizumab and Erlotinib with Radiotherapy for Advanced Head and Neck Cancer
Author(s) -
P. Ahn,
M. Machtay,
P. Anné,
E. Wuthrick,
W. Keane,
D. Cognetti,
Adam P. Dicker,
R. Axelrod
Publication year - 2010
Language(s) - English
DOI - 10.29046/tbj.003.1.021
Subject(s) - erlotinib , docetaxel , bevacizumab , medicine , cisplatin , oncology , head and neck cancer , radiation therapy , erlotinib hydrochloride , cancer , chemotherapy , epidermal growth factor receptor